111 related articles for article (PubMed ID: 14059893)
1. EFFECTS OF 17ALPHA-HYDROXY-6ALPHA-METHYLPROGESTERONE ACETATE (DEPO-PROVERA) ON URINARY GONADOTROPHINS AND OESTROGENS IN MAN.
LARON Z; RUMNEY G; RAT L; NAJI N
Acta Endocrinol (Copenh); 1963 Sep; 44():75-80. PubMed ID: 14059893
[No Abstract] [Full Text] [Related]
2. Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera) as a contraceptive agent.
Jeppsson S; Gershagen S; Johansson ED; Rannevik G
Acta Endocrinol (Copenh); 1982 Mar; 99(3):339-43. PubMed ID: 6461995
[TBL] [Abstract][Full Text] [Related]
3. THE ACTION OF DEPO-PROVERA IN 3 GIRLS WITH IDIOPATHIC ISOSEXUAL PRECOCITY: DECREASE IN ESTROGEN EFFECT WITHOUT URINARY GONADOTROPIN REDUCTION.
LEMLI L; ARON M; SMITH DW
J Pediatr; 1964 Dec; 65():888-94. PubMed ID: 14244096
[No Abstract] [Full Text] [Related]
4. [6alpha-Methyl-17alpha-hydroxyprogesterone acetate (MAP) in high doses and the hypophysis. Experimental contribution].
VERNA F; CASTIGLIONE C
Minerva Ginecol; 1962 Sep; 14():861-8. PubMed ID: 13996820
[No Abstract] [Full Text] [Related]
5. The in vivo metabolism of progestins. IV. The metabolic clearance rate and plasma binding of 6alpha-methylpregn-4-ene-3, 20-dione in women.
Gupta C; Osterman J; Miljković M; Bardin CW
Steroids; 1977 May; 29(5):669-77. PubMed ID: 898233
[TBL] [Abstract][Full Text] [Related]
6. CONSTITUTIONAL ISOSEXUAL PRECOCIOUS PUBERTY. EFFECTS OF MEDROXYPROGESTERONE ACETATE THERAPY.
COLLIPP PJ; KAPLAN SA; BOYLE DC; PLACHTE F; KOGUT MD
Am J Dis Child; 1964 Oct; 108():399-405. PubMed ID: 14186660
[No Abstract] [Full Text] [Related]
7. A case for concern?
Gartland A
Nurs Times; 1983 May 4-10; 79(18):10-1. PubMed ID: 6222288
[TBL] [Abstract][Full Text] [Related]
8. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
van den Berg HW; Martin J; Lynch M
Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
[TBL] [Abstract][Full Text] [Related]
9. BIOLOGIC EFFECTS OF MELENGESTROL ACETATE.
DUNCAN GW; LYSTER SC; HENDRIX JW; CLARK JJ; WEBSTER HD
Fertil Steril; 1964; 15():416-32. PubMed ID: 14192473
[No Abstract] [Full Text] [Related]
10. The urinary excretion of oestrogens, pregnanediol and gonadotrophins during the menstrual cycle.
BROWN JB; KLOPPER A; LORAINE JA
J Endocrinol; 1958 Nov; 17(4):401-10. PubMed ID: 13611153
[No Abstract] [Full Text] [Related]
11. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
Cromer BA; Blair JM; Mahan JD; Zibners L; Naumovski Z
J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232
[TBL] [Abstract][Full Text] [Related]
12. The effect of medroxyprogesterone acetate on gonadotropin secretion in girls with precocious puberty.
Warren MP; Mathews JH; Morishima A; Vande Wiele R
Am J Med Sci; 1975; 269(3):375-81. PubMed ID: 1155493
[TBL] [Abstract][Full Text] [Related]
13. Depo Provera: still controversial.
Wren LM
Int Health News; 1988 Feb; 9(2):2-3, 8. PubMed ID: 12179873
[TBL] [Abstract][Full Text] [Related]
14. Depo-provera: contraceptive risk?
Rosenfield A
Hastings Cent Rep; 1980 Apr; 10(2):4. PubMed ID: 6445344
[TBL] [Abstract][Full Text] [Related]
15. [Research on modifications of thyroid function induced in man by treatment with 6alpha-methyl-17alpha-hydroxy-progesterone acetate].
MAROCCO F
Folia Endocrinol Mens Incretologia Incretoterapia; 1960 Dec; 13(6)Suppl():42-4. PubMed ID: 14470103
[No Abstract] [Full Text] [Related]
16. Drug regulation in the United States and the United Kingdom: the Depo-Provera story.
Richard BW; Lasagna L
Ann Intern Med; 1987 Jun; 106(6):886-91. PubMed ID: 2953290
[TBL] [Abstract][Full Text] [Related]
17. The use of depot medroxyprogesterone acetate (DMPA) injectable contraceptive in Enugu, Nigeria.
Hu E; Ikeako LC; Obiora-Okafor NC
Niger J Med; 2012; 21(3):266-71. PubMed ID: 23304918
[TBL] [Abstract][Full Text] [Related]
18. Exogenous progestins and breast cancer.
Stanford JL; Thomas DB
Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216
[TBL] [Abstract][Full Text] [Related]
19. Treatment of breast cancer with medroxyprogesterone acetate.
Muggia FM; Cassieth PA; Ochoa M; Flatow FA; Gellhorn A; Hyman GA
Ann Intern Med; 1968 Feb; 68(2):328-37. PubMed ID: 4306126
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
